Karmanos Cancer Institute Study Coordinator — Detroit, Michigan

Karmanos Cancer Institute Study Coordinator is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Study Coordinator has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Selected Solid Tumors.

Sponsors: Array Biopharma, now a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Study Coordinator?

Karmanos Cancer Institute Study Coordinator has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Study Coordinator conducted?

Karmanos Cancer Institute Study Coordinator has 1 clinical trials on record. Their work covers Advanced Solid Tumors, Selected Solid Tumors.

Is Karmanos Cancer Institute Study Coordinator accredited by Crixeo Health?

Karmanos Cancer Institute Study Coordinator has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Study Coordinator?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.